BRPI0719393A2 - Composição farmacêutica - Google Patents
Composição farmacêuticaInfo
- Publication number
- BRPI0719393A2 BRPI0719393A2 BRPI0719393A BRPI0719393A2 BR PI0719393 A2 BRPI0719393 A2 BR PI0719393A2 BR PI0719393 A BRPI0719393 A BR PI0719393A BR PI0719393 A2 BRPI0719393 A2 BR PI0719393A2
- Authority
- BR
- Brazil
- Prior art keywords
- pharmaceutical composition
- pharmaceutical
- composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4365—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system having sulfur as a ring hetero atom, e.g. ticlopidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2006330375 | 2006-12-07 | ||
| JP2006-330375 | 2006-12-07 | ||
| PCT/JP2007/073552 WO2008072535A1 (ja) | 2006-12-07 | 2007-12-06 | 低置換度ヒドロキシプロピルセルロースを含有する医薬組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| BRPI0719393A2 true BRPI0719393A2 (pt) | 2015-03-31 |
| BRPI0719393B1 BRPI0719393B1 (pt) | 2020-11-10 |
| BRPI0719393B8 BRPI0719393B8 (pt) | 2021-05-25 |
Family
ID=39511555
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0719393A BRPI0719393B8 (pt) | 2006-12-07 | 2007-12-06 | composição farmacêutica |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US9034860B2 (pt) |
| EP (1) | EP2100610A4 (pt) |
| JP (1) | JP5274261B2 (pt) |
| KR (1) | KR101506043B1 (pt) |
| CN (1) | CN101594865A (pt) |
| BR (1) | BRPI0719393B8 (pt) |
| CA (1) | CA2671979C (pt) |
| TW (1) | TWI482641B (pt) |
| WO (1) | WO2008072535A1 (pt) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7736310B2 (en) | 2006-01-30 | 2010-06-15 | Abbott Diabetes Care Inc. | On-body medical device securement |
| US8346335B2 (en) | 2008-03-28 | 2013-01-01 | Abbott Diabetes Care Inc. | Analyte sensor calibration management |
| CA2672154C (en) * | 2006-12-07 | 2014-11-18 | Daiichi Sankyo Company, Limited | Pharmaceutical composition having improved storage stability |
| CA2823981C (en) * | 2006-12-07 | 2016-05-17 | Daiichi Sankyo Company, Limited | Film-coated preparation having improved stability |
| KR101442862B1 (ko) * | 2006-12-07 | 2014-09-22 | 다이이찌 산쿄 가부시키가이샤 | 만니톨 또는 유당을 함유하는 고형 제제 |
| US8160900B2 (en) | 2007-06-29 | 2012-04-17 | Abbott Diabetes Care Inc. | Analyte monitoring and management device and method to analyze the frequency of user interaction with the device |
| US20110003847A1 (en) | 2008-02-06 | 2011-01-06 | Helm Ag | Prasugrel Salts with Improved Properties |
| US8591410B2 (en) | 2008-05-30 | 2013-11-26 | Abbott Diabetes Care Inc. | Method and apparatus for providing glycemic control |
| US8924159B2 (en) | 2008-05-30 | 2014-12-30 | Abbott Diabetes Care Inc. | Method and apparatus for providing glycemic control |
| WO2010121084A1 (en) | 2009-04-15 | 2010-10-21 | Abbott Diabetes Care Inc. | Analyte monitoring system having an alert |
| EP2425209A4 (en) | 2009-04-29 | 2013-01-09 | Abbott Diabetes Care Inc | METHOD AND SYSTEM FOR REAL-TIME CALIBRATION OF AN ANALYTICAL SENSOR WITH RETROACTIVE FILLING |
| DE102009036646A1 (de) | 2009-08-07 | 2011-02-10 | Ratiopharm Gmbh | Prasugrel in nicht-kristalliner Form und pharmazeutische Zusammensetzung davon |
| EP4147999A1 (en) | 2009-08-31 | 2023-03-15 | Abbott Diabetes Care, Inc. | Displays for a medical device |
| EP2360159A1 (de) * | 2010-02-11 | 2011-08-24 | Ratiopharm GmbH | Prasugrel in mikronisierter, kristalliner Form und pharmazeutische Zusammensetzung davon |
| US10136845B2 (en) | 2011-02-28 | 2018-11-27 | Abbott Diabetes Care Inc. | Devices, systems, and methods associated with analyte monitoring devices and devices incorporating the same |
| US9317656B2 (en) | 2011-11-23 | 2016-04-19 | Abbott Diabetes Care Inc. | Compatibility mechanisms for devices in a continuous analyte monitoring system and methods thereof |
| WO2013078426A2 (en) | 2011-11-25 | 2013-05-30 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods of use |
| CZ2011872A3 (cs) | 2011-12-22 | 2013-07-03 | Zentiva, K.S. | Farmaceutická formulace prasugrelu hydrobromidu |
| DK2830618T3 (en) * | 2012-03-30 | 2016-10-03 | Dae Woong Pharma | A pharmaceutical composition comprising olmesartan medoxomil and rosuvastatin or its salt |
| US8603537B2 (en) | 2012-04-02 | 2013-12-10 | Egis Pharmaceuticals Plc | Prasugrel containing quickly released stable oral pharmaceutical compositions |
| US9907492B2 (en) | 2012-09-26 | 2018-03-06 | Abbott Diabetes Care Inc. | Method and apparatus for improving lag correction during in vivo measurement of analyte concentration with analyte concentration variability and range data |
| EP2722036A1 (en) * | 2012-10-19 | 2014-04-23 | Sanovel Ilac Sanayi ve Ticaret A.S. | Solid oral formulations of prasugrel |
| WO2014060554A1 (en) * | 2012-10-19 | 2014-04-24 | Sanovel Ilac Sanayi Ve Ticaret A.S. | Prasugrel formulations |
| WO2016122421A1 (en) * | 2015-01-29 | 2016-08-04 | Pharmactive Ilaç Sanayi Ve Ticaret A.Ş. | Stable pharmaceutical compositions containing prasugrel base |
| KR101960357B1 (ko) * | 2016-12-26 | 2019-03-20 | 씨제이헬스케어 주식회사 | 벤즈이미다졸 유도체를 포함하는 신규한 제제 |
Family Cites Families (50)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US147951A (en) * | 1874-02-24 | Improvement in car-wheels | ||
| US1656930A (en) * | 1924-01-09 | 1928-01-24 | American Steel Foundries | Method for forging brake-beam fulcrums |
| JPS5942325A (ja) | 1982-09-03 | 1984-03-08 | Dai Ichi Seiyaku Co Ltd | コ−テイング用組成物及びコ−テイング製剤 |
| US5015480A (en) | 1987-11-25 | 1991-05-14 | Eli Lilly And Company | Film coating formulations |
| US5211958A (en) | 1987-11-30 | 1993-05-18 | Gist-Brocades, N.V. | Pharmaceutical composition and process for its preparation |
| ES2047540T3 (es) | 1987-11-30 | 1994-03-01 | Brocades Pharma Bv | Compuesto farmaceutico y procedimiento para su preparacion. |
| JPH01175936A (ja) | 1987-12-28 | 1989-07-12 | Kyorin Pharmaceut Co Ltd | ６．８−ジフルオロ−１−（２−フルオロエチル）−１，４−ジヒドロ−７−（４−メチル−１−ピペラジニル）−４−オキソ−３−キノリンカルボン酸を有効成分とする錠剤 |
| JPH02240024A (ja) | 1989-03-13 | 1990-09-25 | Ss Pharmaceut Co Ltd | 活性型ビタミンｄ↓３類製剤用組成物 |
| US4931286A (en) | 1989-04-19 | 1990-06-05 | Aqualon Company | High gloss cellulose tablet coating |
| FI101150B (fi) | 1991-09-09 | 1998-04-30 | Sankyo Co | Menetelmä lääkeaineina käyttökelpoisten tetrahydrotienopyridiinin johd annaisten valmistamiseksi |
| ZA937382B (en) | 1992-10-06 | 1994-04-29 | Warner Lambert Co | Novel composition for peroral therapy of cognitionimpairment and a process therefor |
| JPH0770506A (ja) | 1993-09-07 | 1995-03-14 | Morishita Roussel Kk | フイルムコーティング組成物およびそれを用いた固形製剤 |
| JP3583166B2 (ja) | 1994-06-27 | 2004-10-27 | 興和株式会社 | 損傷皮膚修復用粉末製剤 |
| GB9414045D0 (en) | 1994-07-12 | 1994-08-31 | Berwind Pharma Service | Moisture barrier film coating composition, method, and coated form |
| JP3274573B2 (ja) | 1994-08-25 | 2002-04-15 | 興和株式会社 | フィルムコーティング組成物およびそれを用いた固形製剤 |
| JPH092953A (ja) | 1995-06-16 | 1997-01-07 | Chugai Pharmaceut Co Ltd | バルフロキサシン製剤 |
| JPH09208458A (ja) | 1996-02-02 | 1997-08-12 | Ss Pharmaceut Co Ltd | 不快な味がマスキングされた製剤 |
| NZ330864A (en) * | 1996-02-29 | 2001-07-27 | Fujisawa Pharmaceutical Co | Beta-lactam antibiotic-containing tablet including a disintegrant and a binder |
| JPH10310586A (ja) * | 1996-06-26 | 1998-11-24 | Sankyo Co Ltd | ヒドロピリジン類の新規医薬用途 |
| KR100343062B1 (ko) | 1996-11-15 | 2002-07-02 | 에가시라 구니오 | 정제 조성물 |
| CA2374760A1 (en) | 1999-06-18 | 2000-12-28 | Takeda Chemical Industries, Ltd. | Quickly disintegrating solid preparations |
| EP1133984B1 (en) * | 2000-03-17 | 2005-05-11 | Shin-Etsu Chemical Co., Ltd. | Solid preparation containing low-substituted hydroxypropyl cellulose and production process thereof |
| FR2807034B1 (fr) | 2000-03-29 | 2002-06-14 | Roquette Freres | Mannitol pulverulent et son procede de fabrication |
| CA2342121C (fr) | 2000-03-29 | 2010-05-25 | Roquette Freres | Mannitol pulverulent et son procede de preparation |
| CZ302990B6 (cs) | 2000-07-06 | 2012-02-08 | Daiichi Sankyo Company, Limited | Adicní soli derivátu hydropyridinu s kyselinou chlorovodíkovou a maleinovou, príprava a použití |
| JP4001199B2 (ja) * | 2000-07-06 | 2007-10-31 | 第一三共株式会社 | ヒドロピリジン誘導体酸付加塩 |
| ATE371439T1 (de) | 2000-07-27 | 2007-09-15 | Roquette Freres | Granulat bestehend aus stärke und laktose |
| AU2002217464B2 (en) | 2000-12-25 | 2004-12-16 | Daiichi Sankyo Company, Limited | Medicinal compositions containing aspirin |
| JP4874482B2 (ja) * | 2000-12-25 | 2012-02-15 | 第一三共株式会社 | アスピリンを含有する医薬組成物 |
| KR100908418B1 (ko) | 2001-06-20 | 2009-07-21 | 액티버스 파마 컴퍼니 리미티드 | 퀴놀리논 유도체 의약 조성물 및 그의 제조 방법 |
| JP3939601B2 (ja) | 2001-06-20 | 2007-07-04 | 株式会社アクティバスファーマ | キノリノン誘導体医薬組成物及びその製造方法 |
| JP2003160500A (ja) | 2001-11-21 | 2003-06-03 | Showa Yakuhin Kako Kk | ポピドンヨード含有組成物 |
| JP4029974B2 (ja) | 2001-12-21 | 2008-01-09 | 第一三共株式会社 | ヒドロピリジン誘導体酸付加塩を含有する医薬 |
| CN1681533A (zh) | 2002-07-18 | 2005-10-12 | 三共株式会社 | 用于治疗动脉硬化的药用组合物 |
| JP2004051639A (ja) | 2002-07-18 | 2004-02-19 | Sankyo Co Ltd | 動脈硬化症治療のための医薬組成物 |
| US20050192245A1 (en) | 2002-07-18 | 2005-09-01 | Sankyo Company, Limited | Medicinal composition for treating arteriosclerosis |
| WO2004091600A1 (ja) | 2003-04-16 | 2004-10-28 | Kyorin Pharmaceutical Co., Ltd. | 経口固形製剤 |
| JP2006525328A (ja) | 2003-05-05 | 2006-11-09 | イーライ リリー アンド カンパニー | 心疾患の治療方法 |
| KR100882156B1 (ko) | 2003-08-08 | 2009-02-06 | 아지노모토 가부시키가이샤 | 나테글리니드 함유 제제 |
| JP5248733B2 (ja) | 2003-11-28 | 2013-07-31 | エスエス製薬株式会社 | 揮散防止型固形製剤およびその製造方法 |
| JP2006206612A (ja) | 2004-05-27 | 2006-08-10 | Ono Pharmaceut Co Ltd | 固形製剤用組成物 |
| EP1656930A1 (en) | 2004-11-10 | 2006-05-17 | Basilea Pharmaceutica AG | Stabilized freeze-dried formulation for cephalosporin derivatives |
| TWI318571B (en) | 2005-06-10 | 2009-12-21 | Lilly Co Eli | Formulation of a thienopyridine platelet aggregation inhibitor |
| EP1893205A4 (en) | 2005-06-17 | 2010-06-30 | Lilly Co Eli | DOSAGE FOR PRASUGREL |
| WO2007020935A1 (ja) | 2005-08-17 | 2007-02-22 | Ono Pharmaceutical Co., Ltd. | Ｐ２ｙ１２受容体および／またはｐ２ｙ１４受容体ブロッカーを含有してなる疼痛治療剤 |
| KR101442862B1 (ko) | 2006-12-07 | 2014-09-22 | 다이이찌 산쿄 가부시키가이샤 | 만니톨 또는 유당을 함유하는 고형 제제 |
| CA2672154C (en) | 2006-12-07 | 2014-11-18 | Daiichi Sankyo Company, Limited | Pharmaceutical composition having improved storage stability |
| KR101503083B1 (ko) | 2006-12-07 | 2015-03-16 | 다이이찌 산쿄 가부시키가이샤 | 고형 제제의 제조 방법 |
| CA2823981C (en) | 2006-12-07 | 2016-05-17 | Daiichi Sankyo Company, Limited | Film-coated preparation having improved stability |
| US20110020814A1 (en) * | 2009-06-05 | 2011-01-27 | Ipierian, Inc. | Methods and compositions for selection of stem cells |
-
2007
- 2007-12-06 TW TW096146464A patent/TWI482641B/zh active
- 2007-12-06 CN CNA200780044970XA patent/CN101594865A/zh active Pending
- 2007-12-06 US US12/312,973 patent/US9034860B2/en active Active
- 2007-12-06 WO PCT/JP2007/073552 patent/WO2008072535A1/ja active Application Filing
- 2007-12-06 KR KR1020097011281A patent/KR101506043B1/ko active IP Right Grant
- 2007-12-06 BR BRPI0719393A patent/BRPI0719393B8/pt active IP Right Grant
- 2007-12-06 EP EP07850168A patent/EP2100610A4/en not_active Ceased
- 2007-12-06 CA CA2671979A patent/CA2671979C/en active Active
- 2007-12-06 JP JP2008549268A patent/JP5274261B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CN101594865A (zh) | 2009-12-02 |
| TWI482641B (zh) | 2015-05-01 |
| JP5274261B2 (ja) | 2013-08-28 |
| KR20090100339A (ko) | 2009-09-23 |
| CA2671979C (en) | 2014-02-04 |
| KR101506043B1 (ko) | 2015-03-25 |
| US9034860B2 (en) | 2015-05-19 |
| US20100093786A1 (en) | 2010-04-15 |
| BRPI0719393B8 (pt) | 2021-05-25 |
| WO2008072535A1 (ja) | 2008-06-19 |
| EP2100610A1 (en) | 2009-09-16 |
| JPWO2008072535A1 (ja) | 2010-03-25 |
| TW200833370A (en) | 2008-08-16 |
| BRPI0719393B1 (pt) | 2020-11-10 |
| CA2671979A1 (en) | 2008-06-19 |
| EP2100610A4 (en) | 2009-12-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| LTPA2018005I1 (lt) | Farmacinė kompozicija | |
| LTPA2018014I1 (lt) | Farmacinė kompozicija 514 | |
| BRPI0715712A2 (pt) | Composição farmacêutica | |
| BRPI0719393A2 (pt) | Composição farmacêutica | |
| BRPI0721651A2 (pt) | Composição farmacêutica | |
| DK2041139T3 (da) | Farmaceutiske forbindelser | |
| RU2398586C3 (ru) | Фармацевтическая композиция | |
| BRPI0716445A2 (pt) | composiÇço farmacÊutica | |
| BRPI0716325A2 (pt) | Composição antimicrobianas | |
| BRPI0720234A2 (pt) | Composição farmacêutica | |
| RU2493831C3 (ru) | Фармацевтические композиции | |
| FR2899479B1 (fr) | Composition cicatrisante | |
| DK2073795T3 (da) | Misbrugssikret lægemiddelformulation | |
| BRPI0810928A2 (pt) | "composição farmacêutica" | |
| DK1940467T3 (da) | Lægemiddelsammensætning med langvarig frigivelse | |
| DK1984009T3 (da) | Farmaceutiske sammensætninger med forbedret stabilitet | |
| DK2120884T3 (da) | Farmaceutisk sammensætning | |
| DK1986650T3 (da) | Manipulationssikre doserignsformer | |
| BRPI0719398A2 (pt) | Composição farmacêutica. | |
| BRPI0719394A2 (pt) | Preparação medicinal sólida | |
| BRPI0716458A2 (pt) | Composição de vulcanizado | |
| DK2285413T3 (da) | Farmaceutisk sammensætning | |
| BRPI0817833A2 (pt) | Composição farmacêutica antimalárica | |
| BRPI0921313A2 (pt) | composição farmaucêutica | |
| BRPI0820198A2 (pt) | composições farmacêuticas |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] |
Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS. |
|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
| B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
| B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 10/11/2020, OBSERVADAS AS CONDICOES LEGAIS. |
|
| B16C | Correction of notification of the grant [chapter 16.3 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 06/12/2007 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF |
|
| B25D | Requested change of name of applicant approved |
Owner name: DAIICHI SANKYO COMPANY LIMITED (JP) ; UBE CORPORATION (JP) |